RxDoctor Payments Data

Krystle Tuano, MD

Plastic and Reconstructive Surgery · Boston, MANPI 1245657261

Payments from drug & device makers

What this record shows

This record is dominated by grants: $12,500 of the $19,808 with a category attached, or 63.1%. Acumed LLC accounts for 63.1% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2022 at $13,460 and has fallen 89.7% since, to $1,391 in 2025.

$19,808in general payments, 2019–2025

Across 56 payments — averaging $353.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acumed LLC$13K
  • Trimed, Inc.$3K
  • BD$1K
  • Integra Lifesciences Corporation$493
  • Axogen$355
  • Sonex Health, Inc.$333
  • plus $2K from 12 others

What the payments were for

  • Speaking & faculty fees$1,1006%
  • Grants$12,50063%
  • Travel & lodging$6233%
  • Food & beverage$5,58528%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,808 in reported general payments places this provider in the 85th percentile of 67 plastic and reconstructive surgery providers in Massachusetts.

See all plastic and reconstructive surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$62,096
Medicare patients
61
Services billed
304

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic and reconstructive surgery in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →